TAK-671

Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda
Endpoints
Mon, 08/21/17 - 10:37 am
Samsung Bioepis
Takeda
drug development
TAK-671
pancreatitis